Enterprise Value
132.6M
Cash
26.45M
Avg Qtr Burn
-11.14M
Short % of Float
8.20%
Insider Ownership
3.63%
Institutional Own.
18.58%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BT-600 Details Inflammatory bowel disease, Ulcerative colitis | Phase 1 Initiation |